ANL 28.52 Increased By ▲ 0.14 (0.49%)
ASC 16.71 Increased By ▲ 0.02 (0.12%)
ASL 23.75 Decreased By ▼ -0.11 (-0.46%)
AVN 94.24 Decreased By ▼ -0.65 (-0.69%)
BOP 9.47 Decreased By ▼ -0.02 (-0.21%)
BYCO 9.57 Decreased By ▼ -0.05 (-0.52%)
DGKC 110.51 Increased By ▲ 0.02 (0.02%)
EPCL 47.50 Decreased By ▼ -0.02 (-0.04%)
FCCL 21.15 Decreased By ▼ -0.15 (-0.7%)
FFBL 27.96 Increased By ▲ 0.08 (0.29%)
FFL 19.27 Decreased By ▼ -0.08 (-0.41%)
HASCOL 14.31 Decreased By ▼ -0.01 (-0.07%)
HUBC 86.00 Decreased By ▼ -0.14 (-0.16%)
HUMNL 7.26 Decreased By ▼ -0.03 (-0.41%)
JSCL 31.45 Decreased By ▼ -0.15 (-0.47%)
KAPCO 40.76 Decreased By ▼ -0.07 (-0.17%)
KEL 4.10 Decreased By ▼ -0.01 (-0.24%)
LOTCHEM 16.19 Increased By ▲ 0.03 (0.19%)
MLCF 43.05 Decreased By ▼ -0.16 (-0.37%)
PAEL 39.85 Increased By ▲ 0.01 (0.03%)
PIBTL 12.90 Decreased By ▼ -0.09 (-0.69%)
POWER 11.40 Decreased By ▼ -0.01 (-0.09%)
PPL 93.29 Decreased By ▼ -0.39 (-0.42%)
PRL 23.80 Decreased By ▼ -0.08 (-0.34%)
PTC 9.30 Decreased By ▼ -0.02 (-0.21%)
SILK 1.21 Decreased By ▼ -0.01 (-0.82%)
SNGP 44.34 Decreased By ▼ -0.14 (-0.31%)
TRG 108.48 Decreased By ▼ -1.23 (-1.12%)
UNITY 33.15 Increased By ▲ 0.04 (0.12%)
WTL 1.12 No Change ▼ 0.00 (0%)
BR100 4,856 Decreased By ▼ -9.94 (-0.2%)
BR30 24,724 Decreased By ▼ -96.85 (-0.39%)
KSE100 45,868 Decreased By ▼ -116.42 (-0.25%)
KSE30 19,061 Decreased By ▼ -87.18 (-0.46%)
Business & Finance

Pakistan’s CCL Pharmaceuticals acquire UAE’s StratHealth Pharma

  • The acquisition of business by CCL will enhance its footprint to an attractive GCC region along side strengthening its consumer and OTC portfolio, read the company statement.
16 Nov 2020

Pakistan’s leading pharmaceuticals firm CCL Pharmaceuticals has acquired 51 percent stake in UAE-based StratHealth Pharma.

StratGurus Group of Companies signed an MoU with Pakistan’s leading CCL Pharmaceuticals that acquired the major shareholder’s status of Dubai-based StratHealth Pharma.

Strathealth Pharma is an upcoming healthcare company based in UAE with an extensive range of Pharma and consumer healthcare products and a promising pipeline. The company offers a strong portfolio of personal care including women health and wound management besides having a nutraceuticals range.

The acquisition of business by CCL will enhance its footprint to an attractive GCC region along side strengthening its consumer and OTC portfolio, read the company statement.

The acquisition will offer a variety of treatment choices to healthcare and consumers in GGC Market in line with CCL’s mission of enabling healthy, happy lives.

At the MoU signing, Dr Tabassum Khan, chairman of StratGurus Group of Companies said: “This acquisition is a well-needed boost for the local pharmaceutical industry. This will strengthen the product portfolio of StratHealth Pharma and provide access to a broader range of healthcare products for consumers in the Gulf countries.”

The chairman of CCL, Kashif Sajjad Sheikh said: “We are privileged to acquire a reputable organisation such as StratHealth Pharma and look forward to strengthening our operations, creating new employment opportunities and providing a comprehensive portfolio of products that will enhance healthier lifestyles and elevate healthcare in the region.”

It is pertinent to mention that CCL Pharmaceuticals is a leading multinational pharmaceutical company with over 50 years of experience in the pursuit of health and wellbeing. CCL’s heritage gives it the strength and capability to help enable healthy and happy communities.